Keros Therapeutics Inc. (KROS) Social Stream

Featured Post From StockTwits About KROS

$KROS New SEC Filing: 8-K Earnings Material Agrmt - Keros Therapeutics, Inc. (0001664710) August 04


Item 1.01 Entry into a Material Definitive Agreement. On August 4, 2021, Keros Therapeutics, Inc. (the "Company") and 99 Hayden LLC, successor-in-interest to 128 Spring Street Lexington, LLC (the "Landlord") entered into the Third Amendment to Lease (the "Amendment"), which amends the lease agreement dated March 20, 2017, as amended by the First Amendment to Lease dated July 1, 2019 and as further amended by the Second Amendment to Lease dated August 8, 2019 (collectively, the "Lease"). Pursuant to the Lease, the Company leased approximately 10,400 square feet of office and laboratory space (the "Initial Premises") in Lexington, Massachusetts, which serve as the Company's headquarters. The A (...)

https://mkn.re/89753